Article Text
Commentaries
Metronomic topotecan for colorectal cancer: a promising new option
Statistics from Altmetric.com
Footnotes
-
Funding This work is supported, in part, by the NIH MERIT award R37 DK47297, RO1 DK 62112, NCI P01 CA77839, and CPRIT RP100960. We also thank the National Colorectal Cancer Research Alliance (NCCRA) for its generous support (RND).
-
Competing interests None.
-
Provenance and peer review Commissioned; externally peer reviewed.